Untargeted Metabolomics of Breast Cancer Cells MCF-7 and SkBr3 Treated With Tamoxifen/Trastuzumab

被引：19
|
作者：
Sharaf, Basma M. [1 ]
Giddey, Alexander D. [2 ]
Alniss, Hasan [1 ,3 ]
Al-Hroub, Hamza M. [3 ]
El-Awady, Raafat [1 ,3 ]
Mousa, Muath [4 ]
Almehdi, Ahmed [4 ,5 ]
Soares, Nelson C. [1 ,3 ]
Semreen, Mohammad H. [1 ,3 ]
机构：
[1] Univ Sharjah, Coll Pharm, Sharjah, U Arab Emirates
[2] Univ Cape Town, Fac Hlth Sci, Dept Integrat Biomed Sci, Cape Town, South Africa
[3] Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates
[4] Univ Sharjah, Res Inst Sci & Engn, Sharjah, U Arab Emirates
[5] Univ Sharjah, Coll Sci, Dept Chem, Sharjah, U Arab Emirates
来源：
CANCER GENOMICS & PROTEOMICS | 2022年 / 19卷 / 01期
关键词：
Untargeted metabolomics; MCF-7; SkBr3; breast cancer cells; UHPLC-trapped ion TIMS-QTOF; tamoxifen; trastuzumab; TCA CYCLE; SUBTYPES; METASTASIS; METABOLISM; TAMOXIFEN; GROWTH; INHIBITION; GLYCOLYSIS; MECHANISM; HALLMARKS;
D O I：
10.21873/cgp.20305
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background/Aim: Trastuzumab and tamoxifen are two of the most widely prescribed anti-cancer drugs for breast cancer (BC). To date, few studies have explored the impact of anticancer drugs on metabolic pathways in BC. Metabolomics is an emerging technology that can identify new biomarkers for tracking therapy response and novel therapeutic targets. Materials and Methods: We employed ultra-high-performance liquid chromatography-quadrupole time of flight mass spectrometry (UHPLC-QTOF-MS) to investigate changes in MCF-7 and SkBr3 cell lines treated with either tamoxifen, trastuzumab or a combination of both. The Bruker Human Metabolome Database (HMDB) metabolite library was used to match spectra and the MetaboScape software to assign each feature with a putative metabolite name or molecular formula for metabolite annotation. Results: A total of 98 metabolites were found to significantly differ in abundance in MCF-7 and SkBr3 treated cells. Moreover, the metabolic profile of the combination medication is similar to that of tamoxifen alone, according to functional enrichment analysis. Conclusion: Tamoxifen/trastuzumab treatment had a significant effect on pathways essential for the control of energy-production, which have previously been linked to cancer progression, and aggressiveness
引用
收藏
页码：79 / 93
页数：15
相关论文
共 50 条
  • [1] Uptake and Cytotoxicity Characterization of Radioiodine in MCF-7 and SKBR3 Breast Cancer Cell Lines
    Elliyanti, A.
    Susilo, V. Y.
    Setiyowati, S.
    Ramli, M.
    Masjhur, J. S.
    Achmad, T. H.
    ATOM INDONESIA, 2016, 42 (03) : 145 - 149
  • [2] Exploring the therapeutic potential of naringin and melatonin in breast cancer: A focus on SKBR3 and MCF-7 cell lines
    Azizpour, Milad
    Changizzadeh, Behnaz
    Golbashirzadeh, Morteza
    Moradzadegan, Atousa
    BIOMEDICAL RESEARCH AND THERAPY, 2025, 12 (02): : 7109 - 7117
  • [3] Effect of GEN1 interference on the chemosensitivity of the breast cancer MCF-7 and SKBR3 cell lines
    Wu, Yunlu
    Qian, Ying
    Zhou, Guozhong
    Lv, Juan
    Yan, Qiuyue
    Dong, Xuejun
    ONCOLOGY LETTERS, 2016, 11 (06) : 3597 - 3604
  • [4] Comparative metabolomics of MCF-7 and MCF-7/TAMR identifies potential metabolic pathways in tamoxifen resistant breast cancer cells
    Mishra, Alok
    Srivastava, Anubhav
    Srivastava, Anshuman
    Sharma, Lokendra Kumar
    Mishra, Anand Kumar
    Shrivastava, Ashutosh
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (04):
  • [5] Comparative proteomic analysis of MCF7 and SKBR3 breast cancer cell lines
    Mojtahedi, Zahra
    Erfani, Nasrollah
    Ghaderi, Abbas
    CANCER RESEARCH, 2012, 72
  • [6] Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells
    Morelli, Maria Beatrice
    Amantini, Consuelo
    Nabissi, Massimo
    Santoni, Giorgio
    Wuensch, Bernhard
    Schepmann, Dirk
    Cimarelli, Cristina
    Pellei, Maura
    Santini, Carlo
    Fontana, Stefano
    Mammoli, Valerio
    Quaglia, Wilma
    Bonifazi, Alessandro
    Giannella, Mario
    Giorgioni, Gianfabio
    Piergentili, Alessandro
    Del Bello, Fabio
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (04): : 511 - 516
  • [7] In Vitro and In Vivo Effects of Xanthorrhizol on Human Breast Cancer MCF-7 Cells Treated With Tamoxifen
    Noomhorm, Nattanant
    Chang, Chun-Ju
    Wen, Che-Sheng
    Wang, Jir-You
    Chen, Jiun-Liang
    Tseng, Ling-Ming
    Chen, Wei-Shone
    Chiu, Jen-Hwey
    Shyr, Yi-Ming
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 125 (04) : 375 - 385
  • [8] Toxicity of trastuzumab labeled 177Lu on MCF7 and SKBr3 cell lines
    Rasaneh, Samira
    Rajabi, Hossein
    Babaei, Mohammad Hossein
    Daha, Fariba Johari
    APPLIED RADIATION AND ISOTOPES, 2010, 68 (10) : 1964 - 1966
  • [9] Antiproliferative effect of trastuzumab and nimotuzumab with EGF on breast cancer cells MCF-7
    Nikulina, V.
    Garmanchuk, L. V.
    Nikolaienko, T. V.
    ANNALS OF ONCOLOGY, 2018, 29
  • [10] Simvastatin Evokes An Unpredicted Antagonism For Tamoxifen In MCF-7 Breast Cancer Cells
    Ibrahim, Amel B.
    Zaki, Hala F.
    Wadie, Walaa
    Omran, Mervat M.
    Shouman, Samia A.
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 10011 - 10028
12345